Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Pinduoduo
PDD
|
$441M |
| 2 |
HDFC Bank
HDB
|
$365M |
| 3 |
Comfort Systems
FIX
|
$202M |
| 4 |
Sea Limited
SE
|
$191M |
| 5 |
ODDITY Tech
ODD
|
$158M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$783M |
| 2 |
Illumina
ILMN
|
$481M |
| 3 |
Mercado Libre
MELI
|
$454M |
| 4 |
Tesla
TSLA
|
$223M |
| 5 |
MarketAxess Holdings
MKTX
|
$166M |
Sector Composition
| 1 | Consumer Discretionary | 29.53% |
| 2 | Technology | 25.11% |
| 3 | Healthcare | 16.35% |
| 4 | Communication Services | 12.72% |
| 5 | Financials | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
226
Block, Inc.
XYZ
$48.5B
| $7.25M | 0.01% | 163,692 -13,618 | -8% | -$603K |
|
227
FTI Consulting
FCN
$5.46B
| $6.69M | 0.01% | 37,509 -2,814 | -7% | -$502K |
|
228
Fortive
FTV
$16.2B
| $6.55M | 0.01% | 88,332 -9,482 | -10% | -$703K |
|
229
Sutro Biopharma
STRO
$72.7M
| $6.48M | 0.01% | 1,867,654 | – | – |
|
230
EOG Resources
EOG
$68.2B
| $6.34M | 0.01% | 50,054 -3,503 | -7% | -$444K |
|
231
Health Catalyst
HCAT
$239M
| $5.74M | 0.01% | 567,136 -23,318 | -4% | -$236K |
|
232
Tandem Diabetes Care
TNDM
$845M
| $5.46M | 0.01% | 262,756 | – | – |
|
233
Globus Medical
GMED
$8.27B
| $5.46M | 0.01% | 109,875 +215 | +0.2% | +$10.7K |
|
234
Nike
NKE
$114B
| $5.29M | ﹤0.01% | 55,301 -3,858 | -7% | -$369K |
|
235
GitLab
GTLB
$7.93B
| $5.14M | ﹤0.01% | 113,574 +1,395 | +1% | +$63.1K |
|
|
HUYA
236
Huya Inc
HUYA
$796M
| $5.01M | ﹤0.01% | 1,765,711 | – | – |
|
237
Oscar Health
OSCR
$4.31B
| $4.58M | ﹤0.01% | 822,088 -278,938 | -25% | -$1.55M |
|
238
Freshpet
FRPT
$2.72B
| $4.06M | ﹤0.01% | 61,611 -988 | -2% | -$65.1K |
|
239
Compañía de Cervecerías Unidas
CCU
$2.29B
| $4.01M | ﹤0.01% | 318,214 -16,900 | -5% | -$213K |
|
240
LivePerson
LPSN
$90.1M
| $4.01M | ﹤0.01% | 1,030,519 | – | – |
|
241
Expensify
EXFY
$182M
| $3.57M | ﹤0.01% | 1,097,896 | – | – |
|
242
Inspire Medical Systems
INSP
$2.77B
| $3.51M | ﹤0.01% | 17,704 +9,875 | +126% | +$1.96M |
|
243
Relay Therapeutics
RLAY
$619M
| $3.32M | ﹤0.01% | 394,450 -16,858 | -4% | -$142K |
|
244
Golub Capital BDC
GBDC
$3.97B
| $2.76M | ﹤0.01% | 187,893 +65,793 | +54% | +$965K |
|
245
Sixth Street Specialty
TSLX
$2.3B
| $2.73M | ﹤0.01% | 133,630 +54,130 | +68% | +$1.11M |
|
|
AKLI
246
DELISTED
Akili, Inc. Common Stock
AKLI
| $2.56M | ﹤0.01% | 4,665,795 | – | – |
|
247
Alector
ALEC
$238M
| $2.38M | ﹤0.01% | 367,972 -17,092 | -4% | -$111K |
|
248
HUTCHMED
HCM
$2.58B
| $2.29M | ﹤0.01% | 135,275 -7,200 | -5% | -$122K |
|
|
NCNA
249
NuCana
NCNA
$6.09M
| $2.23M | ﹤0.01% | 3,659,030 | – | – |
|
|
GOOS
250
Canada Goose Holdings
GOOS
$1.26B
| $2.09M | ﹤0.01% | +142,700 | New | +$2.09M |
|